The Kroger Co (KR) Q2 2026 earnings summary
Event summary combining transcript, slides, and related documents.
Q2 2026 earnings summary
15 Dec, 2025Executive summary
Q2 2025 delivered strong results with 3.4% identical sales growth (ex-fuel), 16% eCommerce growth, and robust performance in pharmacy and fresh categories.
Operating profit reached $863 million, adjusted FIFO operating profit was $1.1 billion, and adjusted EPS grew 12% to $1.04.
Store execution, value offerings, and cost optimization—including 60 store closures and 1,000 staff reductions—supported household growth and profitability.
Leadership team was strengthened, and legal settlements, including with C&S Wholesale Grocers and Albertsons merger termination, were resolved.
E-commerce, pharmacy, and private label brands outperformed, with retail media and alternative profit streams accelerating.
Financial highlights
Q2 2025 sales were $33.94 billion, nearly flat year-over-year; net income attributable to shareholders was $609 million, up from $466 million in Q2 2024.
Gross margin improved to 22.5% from 22.1% year-over-year, driven by the sale of Kroger Specialty Pharmacy and lower supply chain costs.
Adjusted EBITDA for the rolling four quarters was $8.14 billion, with a net total debt to adjusted EBITDA ratio of 1.63.
LIFO charge increased to $62 million from $21 million in Q2 2024.
Cash flow from operations was $3.7 billion YTD, up 6%.
Outlook and guidance
FY25 identical sales guidance (ex-fuel) raised to 2.7%-3.4%; adjusted EPS guidance increased to $4.70-$4.80, and adjusted FIFO operating profit to $4.8-$4.9 billion.
Free cash flow guidance maintained at $2.8-$3.0 billion; capex expected at $3.6-$3.8 billion.
Adjusted tax rate for FY25 revised to 22%.
Q3 identical sales (ex-fuel) expected slightly below full-year midpoint; full-year FIFO gross margin rate expected to be relatively flat.
Latest events from The Kroger Co
- Annual meeting covers director elections, pay, auditors, and a GHG report proposal.KR
Proxy filing13 May 2026 - Board recommends all management proposals, highlights strong results, and opposes GHG proposal.KR
Proxy filing13 May 2026 - Adjusted EPS and operating profit rose, with robust eCommerce and share repurchases in 2025.KR
Q4 202628 Apr 2026 - Dividend raised, strong sales, and all shareholder proposals defeated at the annual meeting.KR
AGM 20253 Feb 2026 - Q1 sales and digital growth offset profit declines as guidance and merger focus remain.KR
Q1 20253 Feb 2026 - Q2 2024 delivered 1.2% sales growth, $0.93 EPS, and strong digital gains amid merger progress.KR
Q2 202520 Jan 2026 - Q3 digital and pharmacy gains offset lower fuel sales; Albertsons merger terminated, $7.5B buyback set.KR
Q3 202511 Jan 2026 - Strong 2024 sales and digital growth set the stage for further gains and capital returns in 2025.KR
Q4 20256 Jan 2026 - Adjusted EPS rose 7% to $1.05, but a $2.6B impairment drove a net loss.KR
Q3 202612 Dec 2025